infliksimabi - search results

Singapore - English - HSA (Health Sciences Authority)

remsima solution for subcutaneous injection 120 mgml in pre-filled syringe

celltrion healthcare singapore private limited - infliximab - injection, solution - infliximab 120mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

remsima sc

celltrion healthcare new zealand limited - infliximab 120 mg/ml - solution for injection - 120 mg/ml - active: infliximab 120 mg/ml excipient: acetic acid polysorbate 80 sodium acetate trihydrate sorbitol water for injection - rheumatoid arthritis remsima sc, in combination with methotrexate, is indicated for the reduction of signs and symptoms as well as the improvement in physical function in: o adult patients with active disease when the response to disease-modifying antirheumatic drugs (dmards), including methotrexate, has been inadequate. o adult patients with severe, active and progressive disease not previously treated with methotrexate or other dmards. in these patient populations, a reduction in the rate of the progression of joint damage, as measured by x-ray, has been demonstrated (see section 5.1).

New Zealand - English - Medsafe (Medicines Safety Authority)

renflexis

samsung bioepis nz limited - infliximab 100mg - powder for injection - 100 mg - active: infliximab 100mg excipient: dibasic sodium phosphate heptahydrate monobasic sodium phosphate monohydrate polysorbate 80 sucrose - ulcerative colitis in adults and children and adolescents (6 to 17 years) renflexis is indicated for the treatment of moderately severe to severe active ulcerative colitis in patients who have had an inadequate response to conventional therapy.